"Pragmatic" clinical trials: From whose perspective?

Evidence-Based Medicine

Volumn 14, Issue 5, 2009, Pages 130-131

  Karanicolas, Paul J ^a   Montori, Victor M ^b   Schünemann, Holger ^c   Guyatt, Gordon H ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MAYO CLINIC   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NORTRIPTYLINE;

CASE REPORT; CIGARETTE SMOKING; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED STUDY; EDITORIAL; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HUMAN; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL RESEARCH; METHODOLOGY; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT PARTICIPATION; PATIENT SATISFACTION; PHYSICIAN; PRESCRIPTION; SMOKING CESSATION;

EID: 70349668313     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/ebm.14.5.130-b     Document Type: Editorial

References (4)

1. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 1967;20:637-648
2. Karanicolas PJ, Montori VM, Devereaux PJ, et al. A new "mechanistic-practical" framework for designing and interpreting randomized trials. J Clin Epidemiol 2009;62:479-484
3. Aveyard P, Johnson C, Fillingham S, et al. Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. BMJ 2008;336:1223-1227 (Pubitemid 351809316)
4. Montori VM, Devereaux PJ, Strauss S, et al. Decision making and the patient. In: Guyatt G, Rennie D, Meade MO, et al, editors. Users' guides to the medical literature: a manual for evidence-based clinical practice. 2nd ed. New York: McGraw-Hill Medical, 2008;643-661